Clinical Trial Update: A Trial to Evaluate the Precision and Accuracy of the NBM-200 Series When Used in a Continuous Prospective Mode

View source ↗

Summary

A clinical trial update evaluating the precision and accuracy of the NBM-200 Series noninvasive monitor in continuous use for anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• NBM-200 Series

Snippet

Sponsor: OrSense, Ltd. | Conditions: Anemia | Status: UNKNOWN